CB GLOBAL (08026) announces its interim results, with a profit attributable to shareholders of approximately HK$4.266 million, turning losses into profits year-on-year.

22:49 12/11/2024

Longhua International Group (08026) released its interim results for the six months ended September 30, 2024, with revenue of approximately 48...

CB GLOBAL (08026) announced its interim performance for the six months ended September 30, 2024. The revenue was approximately HK$48.551 million, representing a year-on-year increase of about 8.3%. The company's net profit attributable to owners was approximately HK$4.266 million, compared to a loss of HK$18.583 million in the same period last year. Earnings per share were 0.29 HK cents.

LUYE PHARMA (02186): Nanjing Greenleaf receives a capital injection of 285 million yuan.

Guoen Technology (02768) is scheduled to accept stock subscriptions from January 27 to January 30, with an expected listing date of February 4th.

CONANT OPTICAL (02276) plans to offer a discount of approximately 11.1% for the sale of 27 million shares, raising approximately HK$1.4 billion.

LUYE PHARMA (02186): Nanjing Greenleaf receives a capital injection of 285 million yuan.

Guoen Technology (02768) is scheduled to accept stock subscriptions from January 27 to January 30, with an expected listing date of February 4th.

CONANT OPTICAL (02276) plans to offer a discount of approximately 11.1% for the sale of 27 million shares, raising approximately HK$1.4 billion.